Studies on the basis for the properties of fibrin produced from fibrinogen-containing γ′ chains

Blood

Volumn 106, Issue 8, 2005, Pages 2730-2736

  Siebenlist, Kevin R ^a   Mosesson, Michael W ^b   Hernandez, Irene ^b   Bush, Leslie A ^b   Di Cera, Enrico ^b   Shainoff, John R ^b   Di Orio, James P ^b   Stojanovic, Laurie ^b  

^a MARQUETTE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; FIBRIN; FIBRINOGEN; FIBRINOPEPTIDE A; THROMBIN;

ALLOSTERISM; ARTICLE; BINDING SITE; BLOOD CLOT LYSIS; CATALYSIS; CROSS LINKING; FIBRIN CLOT; HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE;

EID: 27144433871     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-01-0240     Document Type: Article

References (66)

1. Henschen A, Lottspeich F, Kehl M, Southan C. Covalent structure of fibrinogen. Ann N Y Acad Sci. 1983;408:28-43.
2. Finlayson JS, Mosesson MW. Heterogeneity of human fibrinogen. Biochemistry. 1963;2:42-46.
3. Mosesson MW, Finlayson JS, Umfleet RA. Human fibrinogen heterogeneities, III: identification of γ chain variants. J Biol Chem. 1972;247:5223-5227.
4. Wolfenstein-Todel C, Mosesson MW. Human plasma fibrinogen heterogeneity: evidence for an extended carboxyl-terminal sequence in a normal gamma chain variant (γ′). Proc Natl Acad Sci U S A. 1980;77:5069-5073.
5. Chung DW, Davie EW. γand γ′ chains of human fibrinogen are produced by alternative mRNA processing. Biochemistry. 1984;23:4232-4236.
6. Liu CY, Nossel HY, Kaplan KL. The binding of thrombin by fibrin. J Biol Chem. 1979;254:10421-10425.
7. Berliner LJ, Sugawara Y, Fenton JWI. Human α-thrombin binding to nonpolymerized fibrin-Sepharose: evidence for an anionic binding region. Biochemistry. 1985;24:7005-7009.
8. Fenton JW II, Olson TA, Zabinski MP, Wilner GD. Anion-binding exosite of human α-thrombin and fibrin(ogen) recognition. Biochemistry. 1988;27:7106-7112.
9. Kudryk B, Reuterby J, Blombäck B. Adsorption of plasmic fragment D to thrombin modified fibrinogen-Sepharose. Thromb Res. 1973;2:297-304.
10. Blombäck B, Hessel B, Hogg D, Therkildsen L. A two-step fibrinogen-fibrin transition in blood coagulation. Nature. 1978;275:501-505.
11. Olexa SA, Budzynski AZ. Evidence for four different polymerization sites involved in human fibrin formation. Proc Natl Acad Sci U S A. 1980;77:1374-1378.
12. Budzynski AZ, Olexa SA, Pandya BV. Fibrin polymerization sites in fibrinogen and fibrin fragments. Ann N Y Acad Sci. 1983;408:301-314.
13. Laudano AP, Cottrell BA, Doolittle RF. Synthetic peptides modeled on fibrin polymerization sites. Ann N Y Acad Sci. 1983;408:315-329.
14. Shainoff JR, Dardik BN. Fibrinopeptide B in fibrin assembly and metabolism: physiologic signifi-cance in delayed release of the peptide. Ann N Y Acad Sci. 1983;408:254-267.
15. Ferry JD. The mechanism of polymerization of fibrinogen. Proc Natl Acad Sci U S A. 1952;38:566-569.
16. 2+-related regulatory function of fibrinogen. Proc Natl Acad Sci U S A. 1978;75:4234-4237.
17. Janus TJ, Lewis SD, Lorand L, Shafer JA. Promotion of thrombin-catalyzed activation of factor XIII by fibrinogen. Biochemistry. 1983;22:6268-6272.
18. Greenberg CS, Miraglia CC, Rickles FR, Shuman MA. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting. J Clin Invest. 1985;75:1463-1470.
19. Lewis SD, Janus TJ, Lorand L, Shafer JA. Regulation of formation of factor XIIIa by its fibrin substrates. Biochemistry. 1985;24:6772-6777.
20. Naski MC, Lorand L, Shafer JA. Characterization of the kinetic pathway for fibrin promotion of alpha-thrombin-catalyzed activation of plasma factor XIII. Biochemistry. 1991;30:934-941.
21. Procyk R, Bishop PD, Kudryk B. Fibrin-recombinant human factor XIII a-subunit association. Thromb Res. 1993;71:127-138.
22. Pisano JJ, Finlayson JS, Peyton MP. Crosslink in fibrin polymerized by factor XIII: ε-(γ-glutamyl)-lysine. Science. 1968;160:892-893.
23. Shainoff JR, Urbanic DA, DiBello PM. Immunoelectrophoretic characterizations of the crosslinking of fibrinogen and fibrin by factor XIIIa and tissue transglutaminase: identification of a rapid mode of hybrid alpha-/gamma-chain cross-linking that is promoted by the gamma-chain crosslinking. J Biol Chem. 1991;266:6429-6437.
24. McKee PA, Mattock P, Hill RL. Subunit structure of human fibrinogen, soluble fibrin, and crosslinked insoluble fibrin. Proc Natl Acad Sci U S A. 1970;66:738-744.
25. Meh DA, Siebenlist KR, Mosesson MW. Identifi-cation and characterization of the thrombin binding sites on fibrin. J Biol Chem. 1996;271:23121-23125.
26. Siebenlist KR, Meh DA, Mosesson MW. Plasma factor XIII binds specifically to fibrinogen molecules containing γ chains. Biochemistry. 1996;35:10448-10453.
27. Falls LA, Farrell DH. Resistance of γA/γ′ fibrin clots to fibrinolysis. J Biol Chem. 1997;272:14251-14256.
28. Moaddel M, Falls LA, Farrell DH. The role of γA/γ′ fibrinogen in plasma factor XIII activation. J Biol Chem. 2000;278:32135-32140.
29. Cooper AV, Standeven KF, Ariens RA. Fibrinogen gamma-chain splice variant gamma' alters fibrin formation and structure. Blood. 2003;102:535-540.
30. Collet JP, Nagaswami C, Farrell DH, Montalescot G, Weisel JW. Influence of gamma′ fibrinogen splice variant on fibrin physical properties and fibrinolysis rate. Arterioscler Thromb Vasc Biol. 2004;24:382-386.
31. Mosesson MW, Hernandez I, Siebenlist KR. Evidence that catalytically-inactivated thrombin forms non-covalently linked dimers that bridge between fibrin/fibrinogen fibers and enhance fibrin polymerization. Biophys Chem. 2004;110:93-100.
32. Pospisil CH, Stafford AR, Fredenburgh JC, Weitz JI. Evidence that both exosites on thrombin participate in its high affinity interaction with fibrin. J Biol Chem. 2003;278:21584-21591.
33. Lovely RS, Moaddel M, Farrell DH. Fibrinogen γ′ chain binds thrombin exosite II. J Thromb Haemost. 2003;1:124-131.
34. Gabriel DA, Muga K, Boothroyd EM. The effect of fibrin structure on fibrinolysis. J Biol Chem. 1992;267:24259-24263.
35. Collet JP, Soria J, Mirshahi M, et al. Dusart syndrome: a new concept of the relationship between fibrin clot architecture and fibrin clot degradability: hypofibrinolysis related to an abnormal clot structure. Blood. 1993;82:2462-2469.
36. Collet JP, Park D, Lesty C, et al. Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy. Arterioscler Thromb Vasc Biol. 2000;20:1354-1361.
37. Mosesson MW, Sherry S. The preparation and properties of human fibrinogen of relatively high solubility. Biochemistry. 1966;5:2829-2835.
38. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
39. Belitser VA, Varetskaja TV, Malneva GV. Fibrinogen-fibrin interaction. Biochim Biophys Acta. 1968;154:367-375.
40. Mosesson MW, Finlayson JS. Subfractions of human fibrinogen: preparation and analysis. J Lab Clin Med. 1963;62:663-674.
41. Lorand L, Gotoh T. Fibrinoligase: the fibrin stabilizing factor. Methods Enzymol. 1970;19:770-782.
42. Loewy AG, Dunathan K, Kriel R, Wolfinger HL. Fibrinase I: purification of substrate and enzyme. J Biol Chem. 1961;236:2625-2633.
43. Schwartz ML, Pizzo SV, Hill RL, McKee PA. Human factor XIII from plasma and platelets: molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin. J Biol Chem. 1973;248:1395-1407.
44. Kanaide H, Shainoff JR. Cross-linking of fibrinogen and fibrin by fibrin-stabilizing factor (factor XIIIa). J Lab Clin Med. 1975;85:574-597.
45. Mosesson MW, Siebenlist KR, Hainfeld JF, Wall JS. The covalent structure of factor XIIIa crosslinked fibrinogen fibrils. J Struct Biol. 1995;115:88-101.
46. Schwartz ML, Pizzo SV, Hill RL, McKee PA. The subunit structures of human plasma and platelet factor XIII (fibrin-stabilizing factor). J Biol Chem. 1971;246:5851-5854.
47. Ashcroft AE, Grant PJ, Ariens RA. A study of human coagulation factor XIII A-subunit by electrospray ionisation mass spectrometry. Rapid Commun Mass Spectrom. 2000;14:1607-1611.
48. Glidden PF, Malaska C, Herring SW. Thromboelastograph assay for measuring the mechanical strength of fibrin sealant clots. Clin Appl Thromb Hemost. 2000;6:226-233.
49. Traverso CI, Caprini JA, Arcelus JI. The normal thromboelastogram and its interpretation. Semin Thromb Hemost. 1995;21(suppl 4):7-13.
50. Shainoff JR, Urbanic DA, DiBello PM, Valenzuela V. GPR-phoresis, a novel approach to determining fibrin monomer and other macromolecular derivatives of fibrinogen and fibrin in blood. Blood Coagul Fibrinolysis. 1993;4:87-92.
51. Shainoff JR, Smejkal GB, DiBello PM, et al. Isolation and characterization of the fibrin intermediate arising from cleavage of one fibrinopeptide A from fibrinogen. J Biol Chem. 1996;271:24129-24137.
52. Shainoff JR, Smejkal GB, DiBello PM, et al. Allosteric effects potentiating the release of the second fibrinopeptide A from fibrinogen by thrombin. J Biol Chem. 2002;277:19367-19373.
53. Meh DA, Siebenlist KR, Brennan SO, Holyst T, Mosesson MW. The amino acid sequences in fibrin responsible for high affinity thrombin binding. Thromb Haemost. 2001;85:470-474.
54. Hopfner KP, Di Cera E. Energetics of thrombin-fibrinogen interaction. Biochemistry. 1992;31:11567-11571.
55. Root-Bernstein RS, Westall FC. Fibrinopeptide A binds Gly-Pro-Arg-Pro. Proc Natl Acad Sci U S A. 1984;81:4339-4342.
56. Pineda AO, Carrell CJ, Bush LA, et al. Molecular dissection of Na binding to thrombin. J Biol Chem. 2004;279:31842-31853.
57. Pirkle H. Thrombin-like enzymes from snake venoms: an updated inventory: Scientific and Standardization Committee's Registry of Exogenous Hemostatic Factors. Thromb Haemost. 1998;79:675-683.
58. Meh DA, Mosesson MW, DiOrio JP, et al. Disintegration and reorganization of fibrin networks during tissue-type plasminogen activator-induced clot lysis. Blood Coagul Fibrinolysis. 2001;12:627-637.
59. Blombäck B, Carlsson K, Fatah K, et al. Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation. Thromb Res. 1994;75:521-538.
60. Credo RB, Curtis CG, Lorand L. Alpha-chain domain of fibrinogen controls generation of fibrinoligase (coagulation factor XIIIa): calcium ion regulatory aspects. Biochemistry. 1981;20:3770-3778.
61. Bock PE. Active-site-selective labeling of blood coagulation proteinases with fluorescence probes by the use of thioester peptide chloromethyl ketones, II: properties of thrombin derivatives as reporters of prothrombin fragment 2 binding and specificity of the labeling approach for other proteinases. J Biol Chem. 1992;267:14974-14981.
62. Liaw PC, Fredenburgh JC, Stafford AR, et al. Localization of the thrombin-binding domain on prothrombin fragment 2. J Biol Chem. 1998;273:8932-8939.
63. Fredenburgh JC, Stafford AR, Weitz JI. Evidence for allosteric linkage between exosites 1 and 2 of thrombin. J Biol Chem. 1997;272:25493-25499.
64. Colwell NS, Blinder MA, Tsiang M, et al. Allosteric effects of a monoclonal antibody against thrombin exosite II. Biochemistry. 1998;37:15057-15065.
65. Li CQ, Vindigni A, Sadler JE, Wardell MR. Platelet glycoprotein Ib alpha binds to thrombin anionbinding exosite II inducing allosteric changes in the activity of thrombin. J Biol Chem. 2001;276:6161-6168.
66. Tasset DM, Kubik MF, Steiner W. Oligonucleotide inhibitors of human thrombin that bind distinct epitopes. J Mol Biol. 1997;272:688-698.